Accessibility Menu
AdaptHealth Stock Quote

AdaptHealth (NASDAQ: AHCO)

$9.28
(-1.7%)
-0.16
Price as of October 23, 2025, 12:28 p.m. ET

KEY DATA POINTS

Current Price
$9.28
Daily Change
(-1.7%) $0.16
Day's Range
$9.25 - $9.51
Previous Close
$9.44
Open
$9.44
Beta
1.06
Volume
133,261
Average Volume
1,005,364
Market Cap
1.3B
Market Cap / Employee
$9.44M
52wk Range
$7.11 - $11.63
Revenue
-
Gross Margin
0.17%
Dividend Yield
N/A
EPS
$0.53
CAPs Rating
-
Industry
Healthcare Providers and Services

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

AdaptHealth Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
AHCO-13.79%-66.92%-19.85%-2%
S&P+14.5%+93.32%+14.09%+117%

AdaptHealth Company Info

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$800.37M-0.7%
Gross Profit$144.46M25.0%
Gross Margin18.05%3.7%
Market Cap$1.27B-4.5%
Market Cap / Employee$0.12M0.0%
Employees10.5K-1.9%
Net Income$14.59M-22.7%
EBITDA$160.72M0.9%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$68.63M-1.7%
Accounts Receivable$393.59M-9.9%
Inventory148.920.1%

Liabilities

Q2 2025YOY Change
Long Term Debt$1.89B-11.9%
Short Term Debt$59.69M-27.5%

Ratios

Q2 2025YOY Change
Return On Assets1.65%15.9%
Return On Invested Capital-5.08%1.7%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$73.33M-37.2%
Operating Free Cash Flow$161.99M-18.2%

Valuation

MetricQ4 2024Q1 2025Q2 2025YoY Change
Price to Earnings15.7419.1017.63-
Price to Book0.980.830.930.79-10.21%
Price to Sales0.470.400.450.40-4.39%
Price to Tangible Book Value-1.08-0.96-1.21-1.0713.89%
Price to Free Cash Flow TTM6.695.515.325.59-31.68%
Enterprise Value to EBITDA20.9316.9726.9119.79-10.58%
Free Cash Flow Yield15.0%18.1%18.8%17.9%46.38%
Return on Equity-13.4%5.5%5.1%4.8%-112.60%
Total Debt$2.18B$2.13B$2.10B$1.95B-12.51%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.